There is accumulating evidence that non-phagocytic NADPH oxidases are major enzymatic sources of ROS generation in ischemia-reperfusion injury, inflammation, hypertension, and atherosclerosis based on experimental animal and human studies [19, 20]. The gene discussed is FMO5; the disease is hypertensive disorder.